PZNSL-Register / NOA-13 Prospektive Beobachtungsstudie zur Chemotherapie bei nicht spezifisch vorbehandelten Patienten mit primärem ZNS-Lymphom (PZNSL) (Aktiv)
VALIDATE An Open Label, Phase I/II Study to Investigate the Use of VORAXAZE™ as Intended Intervention in Patients With Central Nervous System Lymphoma and With Impaired Renal Function Being Treated With High-dose Methotrexate (Aktiv)
Erstlinie
MTR2 Pilot-trial of methotrexate, tafasitamab (Minjuvi®), lenalidomide (Revlimid®) and rituximab in patients ineligible r HCT-ASCT with primary central nervous system for lymphoma (PCNSL) (Aktiv)
OptiMATe Optimizing MATRix as Remission Induction in PCNSL: De-escalated Induction Treatment in Newly Diagnosed Primary CNS Lymphoma - a Randomized Phase III Trial (Aktiv)
PRIMACNS Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly CNS lymphoma pa-tients ? a randomized phase III trial (Aktiv)